Oscar Health (NYSE:OSCR – Free Report) had its price objective boosted by Wells Fargo & Company from $20.00 to $24.00 in a report released on Thursday, Benzinga reports. They currently have an overweight rating on the stock.
A number of other research analysts have also commented on the stock. TheStreet raised shares of Oscar Health from a d rating to a c- rating in a research report on Wednesday, February 21st. Raymond James started coverage on Oscar Health in a report on Friday, March 22nd. They issued an outperform rating and a $20.00 price target for the company. Finally, The Goldman Sachs Group raised their price objective on Oscar Health from $16.00 to $21.00 and gave the stock a neutral rating in a research report on Thursday. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of Moderate Buy and an average target price of $15.00.
Read Our Latest Report on Oscar Health
Oscar Health Stock Performance
Shares of NYSE OSCR opened at $21.64 on Thursday. Oscar Health has a 12 month low of $4.72 and a 12 month high of $22.68. The company has a market cap of $4.97 billion, a P/E ratio of -54.10 and a beta of 1.66. The business’s 50 day moving average is $15.72 and its two-hundred day moving average is $12.31. The company has a quick ratio of 1.19, a current ratio of 1.10 and a debt-to-equity ratio of 0.29.
Oscar Health (NYSE:OSCR – Get Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.34. The business had revenue of $2.14 billion for the quarter, compared to the consensus estimate of $1.99 billion. Oscar Health had a negative net margin of 0.82% and a negative return on equity of 5.77%. Oscar Health’s quarterly revenue was up 45.8% on a year-over-year basis. During the same quarter last year, the company posted ($0.18) earnings per share. On average, equities analysts expect that Oscar Health will post -0.04 EPS for the current year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OSCR. Precision Wealth Strategies LLC bought a new stake in shares of Oscar Health in the 3rd quarter valued at approximately $60,000. SG Americas Securities LLC acquired a new stake in Oscar Health in the 3rd quarter valued at $62,000. Avalon Trust Co acquired a new stake in Oscar Health in the 1st quarter valued at $69,000. Brown Advisory Inc. bought a new stake in Oscar Health in the third quarter valued at $83,000. Finally, Amalgamated Bank raised its stake in Oscar Health by 10.6% during the third quarter. Amalgamated Bank now owns 15,762 shares of the company’s stock worth $88,000 after acquiring an additional 1,516 shares in the last quarter. Institutional investors own 75.70% of the company’s stock.
Oscar Health Company Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
Receive News & Ratings for Oscar Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Oscar Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
